1,2-Dimethylhydrazine-induced colon carcinoma and lymphoma in msh2-/- mice

Journal of the National Cancer Institute

Volumn 93, Issue 20, 2001, Pages 1534-1540

  Colussi, Claudia ^a   Fiumicino, Silvia ^a   Giuliani, Alessandro ^a   Rosini, Sandra ^b   Musiani, Piero ^b   Macrí, Caterina ^a   Potten, Christopher S ^c   Crescenzi, Marco ^a   Bignami, Margherita ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

^c CHRISTIE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

1,2 DIMETHYLHYDRAZINE; CARCINOGEN; GENE PRODUCT; PROTEIN MSH2; UNCLASSIFIED DRUG;

ANGIOSARCOMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BASE MISPAIRING; CANCER INCIDENCE; CANCER SUSCEPTIBILITY; CELL DAMAGE; CELL PROLIFERATION; COLON CARCINOMA; CONTROLLED STUDY; DEATH; DNA REPAIR; FAMILIAL CANCER; FEMALE; GASTROINTESTINAL TRACT; GENOTYPE; HETEROZYGOSITY; HISTOPATHOLOGY; HOMOZYGOSITY; INTESTINE CRYPT; INTESTINE EPITHELIUM; KIDNEY CAPSULE; LARGE INTESTINE; LYMPHOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMALL INTESTINE; STATISTICAL ANALYSIS; TIME; TRICHOEPITHELIOMA; TUMOR LOCALIZATION;

EID: 0035904330     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.20.1534     Document Type: Article

References (40)

1. Mismatch repair in replication fidelity, genetic recombination, and cancer biology
2. Hereditary nonpolyposis colorectal cancer (Lynch syndromes I and II). I. Clinical description of resource
3. Mammalian DNA mismatch repair
4. MSH2 deficient mice are viable and susceptible to lymphoid tumours
5. Inactivation of the mouse Msh2 gene results in mismatch repair deficiency, methylation tolerance, hyperrecombination, and predisposition to cancer
6. Mutation in the mismatch repair gene Msh6 causes cancer susceptibility
7. Tumour susceptibility and spontaneous mutation in mice deficient in Mlh1, Pms1 and Pms2 DNA mismatch repair
8. Defective mismatch binding and a mutator phenotype in cells tolerant to DNA damage
9. An alkylation-tolerant, mutator human cell line is deficient in strand-specific mismatch repair
10. 6-alkylguanine-DNA alkyltransferase: Regulation and importance in response to alkylating carcinogenic and therapeutic agents
11. 6-alkylguanine-DNA alkyltransferase activity in normal human tissues and cells
12. DNA mismatch binding and incision at modified guanine bases by extracts of mammalian cells: Implications for tolerance to DNA methylation damage
13. 4-methylthymine, or the cisplatin d(GpG) adduct
14. Involvement of the mismatch repair system in temozolomide-induced apoptosis
15. 6-alkylguanine DNA lesions trigger apoptosis
16. Role of DNA mismatch repair and p53 in signaling induction of apoptosis by alkylating agents
17. 6-methylguanine and the cytotoxicity of methylating agents
18. 6-alkylguanine-DNA alkyltransferase
19. Tissues of MSH2-deficient mice demonstrate hypermutability on exposure to a DNA methylating agent
20. The detection of alkylation damage in the DNA of human gastrointestinal tissues
21. Frequency of Ki-ras mutations and DNA alkylation in colorectal tissue from individuals living in Manchester
22. 6-alkylguanine DNA-alkyltransferase activity in normal colorectal tissue is associated with colorectal tumours containing a GC→AT transition in the K-ras oncogene
23. 1,2-Dimethylhydrazine-induced methylation of DNA bases in various rat organs and the effect of pretreatment with disulfiram
24. Induction of adenocarcinomas of the colon in mice by weekly injections of 1,2-dimethylhydrazine
25. Effects of methylazoxymethanol acetate on inbred mice: Influence of genetic factors on tumor induction
26. Spontaneous intestinal carcinomas and skin neoplasms in Msh2-deficient mice
27. Mouse models for hereditary nonpolyposis colorectal cancer
28. Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine
29. Nonparametrics: Statistical methods based on ranks
30. Target cells for the cytotoxic effects of carcinogens in the murine small bowel
31. Role of host factors in carcinogenesis induced in mice by 1,2-dimethylhydrazine
32. Separation of killing and tumorigenic effects of an alkylating agent in mice defective in two of the DNA repair genes
33. Mice defective in the DNA mismatch gene PMS2 are hypersensitive to MNU induced thymic lymphoma and are partially protected by transgenic expression of human MGMT
34. A possible explanation for the differential cancer incidence in the intestine, based on distribution of the cytotoxic effects of carcinogens in the murine large bowel
35. A defect in a single allele of the Mlh1 gene causes dissociation of the killing and tumorigenic actions of an alkylating carcinogen in methyltransferase-deficient mice
36. Production of intestinal and other tumors by 1,2-dimethylhydrazine dihydrochloride in mice. I. A light and transmission electron microscopic study of colonic neoplasms
37. Heterozygous DNA mismatch repair gene PMS2-knockout mice are susceptible to intestinal tumor induction with N-methyl-N-nitrosourea
38. Mismatch repair and differential sensitivity of mouse and human cells to methylating agents
39. Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type I
40. Neurofibromatosis and early onset of cancers in hMLH1-deficient children